iifl-logo

Bafna Pharmaceuticals Ltd Cash Flow Statement

78.99
(2.69%)
Apr 25, 2025|09:49:16 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Bafna Pharma. FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

7.3

5.82

-1.87

-14.27

Depreciation

-5.49

-4.47

-3.26

-3.64

Tax paid

0

0

0

-2.17

Working capital

-0.75

16.58

6.23

-27.03

Other operating items

Operating

1.06

17.92

1.08

-47.12

Capital expenditure

8.37

5.47

1.55

0.13

Free cash flow

9.43

23.4

2.63

-46.99

Equity raised

66.26

97.15

69.36

64.64

Investing

0

0

-1.43

-16.9

Financing

21.35

18.31

-39.18

-31.36

Dividends paid

0

0

0

0

Net in cash

97.05

138.87

31.38

-30.61

Bafna Pharma. : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.